Bio Rad Laboratories Class A financial statements
바이오 래드 래브러토리스NYSE:BIO · New York Stock Exchange · Healthcare · sector #13$379.82+2.89%
2026-10-05 closeBio Rad Laboratories Class A's published financial data is dated 2026-10-04. 2024 revenue was $2.57B. 2024 operating profit was $269M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy